Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Medical Countermeasures mRNA Vaccine Platform Shows Promise Against Pandemic Influenza Strains, Including H5N1Global Biodefense StaffApril 26, 2026
Medical Countermeasures UK Launches Phase 3 Trial of mRNA H5N1 Vaccine in Bid to Get Ahead of Next PandemicGlobal Biodefense StaffApril 23, 2026
Soligenix to Present at Chemical and Biological Defense S&T Conference Antimicrobial Resistance May 4, 2015 …
G7 Nations Call for Action on Antibiotic Resistance, Tropical Diseases Antimicrobial Resistance May 4, 2015 …
Seattle BioMed Rebrands as Center for Infectious Disease Research Medical Countermeasures April 28, 2015 …
